Back

Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien XT valve (TRICAVAL): a controlled prospective randomized trial

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 2 - Best Posters in non coronary cardiac intervention Tricuspid Valve Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Michael Laule

Martin-Luther-Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Discussant: Best Posters in non coronary cardiac intervention
Presentation thumbnail
Sustained long term benefits after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a single centre experience
Doctor M. Cheuk (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Renal denervation as antiarrhythmic strategy in recurrent ventricular arrhythmias in patients with implanted cardioverter-defibrillators
Mr D. Goncharik (Minsk, BY)
Abstract Slides
Presentation thumbnail
Comparison of the safety and efficacy of balloon expandable Vs. self expandable aortic valve prosthesis in women undergoing transcatheter aortic valve replacement
Doctor C. Giannini (Pisa, IT)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 2 - Best Posters in non coronary cardiac intervention

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Image guidance for transcatheter procedures: when is it a challenge?
thumbnail
Congress Presentation
Echocardiography to select candidates for transcatheter tricuspid valve replacement
thumbnail
Congress Session
Novel approaches to patients with symptomatic tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources